BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20837276)

  • 1. Hematemesis in a 2009 H1N1 influenza patient.
    Adalja AA
    Am J Emerg Med; 2010 Sep; 28(7):846.e3-4. PubMed ID: 20837276
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
    Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
    Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuraminidase inhibitors and high risk of influenza complications: considered and widely-supported recommendations].
    van Dissel JT; Coutinho RA; van der Sande MA
    Ned Tijdschr Geneeskd; 2009; 153():B486. PubMed ID: 20051160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of antiviral agents for the management of severe influenza.
    Smith JR; Ariano RE; Toovey S
    Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A/H1N1 flu. Time for case-control studies of NSAIDs and oseltamivir.
    Herxheimer A; Clarke M; Edwards R; Jefferson T; Loke Y
    BMJ; 2009 Jul; 339():b3048. PubMed ID: 19638383
    [No Abstract]   [Full Text] [Related]  

  • 7. Suspected oseltamivir-induced bradycardia.
    Karplus R; Sanset S; Zaidenstein R; Schneider D; Berkovitch M
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e374-5. PubMed ID: 20615742
    [No Abstract]   [Full Text] [Related]  

  • 8. [No evidence of fewer influenza complications with oseltamivir].
    Bonneux L
    Ned Tijdschr Geneeskd; 2009; 153():A1127. PubMed ID: 19857319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of oseltamivir resistance during oseltamivir therapy in a child with severe 2009 H1N1 influenza.
    Glikman D; Zonis Z; Hindiyeh M; Ram D; Mandelboim M; Mendelson E; Engelhard D
    Pediatr Infect Dis J; 2010 Apr; 29(4):385-6. PubMed ID: 20351533
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamiflu: what dermatologists need to know.
    Bergstrom KG
    J Drugs Dermatol; 2010 Jan; 9(1):76-8. PubMed ID: 20120431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oseltamivir- related psychiatric manifestations.
    Guisado-Macías JA; Rodríguez FF; Méndez-Sánchez F; Bolívar-Perálvarez M
    Actas Esp Psiquiatr; 2012; 40(1):46-8. PubMed ID: 22344496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent jump case in Japan associated with influenza but not oseltamivir.
    Terada K; Kawai Y; Monju A; Wakabayashi T; Ouchi K
    Pediatr Infect Dis J; 2008 Jan; 27(1):88-9. PubMed ID: 18162953
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.
    Dharan NJ; Gubareva LV; Klimov AI; Fiore AE; Bresee JS; Fry AM
    Clin Infect Dis; 2010 Feb; 50(4):621-2. PubMed ID: 20095841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
    Aardema H; Tulleken JE; van den Biggelaar RJ; Wolters BA; de Jager CM; Boucher CA; Riezebos-Brilman A
    Ned Tijdschr Geneeskd; 2010; 154():A1634. PubMed ID: 20482913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
    J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mania in a patient with H1N1: is oseltamivir the culprit or a red herring?
    Khandaker GM; Khandaker GM; Dibben C; Zurynski Y; Elliott EJ; Booy R
    Am J Psychiatry; 2010 Sep; 167(9):1129-30; author reply 1130. PubMed ID: 20826864
    [No Abstract]   [Full Text] [Related]  

  • 19. Oseltamivir-induced mania in a patient with H1N1.
    Ho LN; Chung JP; Choy KL
    Am J Psychiatry; 2010 Mar; 167(3):350. PubMed ID: 20194491
    [No Abstract]   [Full Text] [Related]  

  • 20. Oseltamivir treatment for influenza does not increase digestive intolerance in preterm infants.
    Leick-Courtois C; Haÿs S; Basson E; Mory-Thomas N; Boibieux A; Picaud JC
    Acta Paediatr; 2014 Mar; 103(3):e136-7. PubMed ID: 24372794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.